Skip to main content
Screener/Healthcare/Biotechnology

IMVT — Immunovant, Inc.

NASDAQ
$29.11+1.86 (+6.83%)
Mid CapUnder $50HealthcareLow Beta
$13.36
$30.09
$27.16
$29.85
EPS (TTM)$-2.69
P/E Ratio-10.55
Dividend Yield—
Market Cap$5.52B
Volume1.33M
Prev Close$27.22
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '26$0-$110.6M$-0.61——
Q2 '26$0-$126.5M$-0.73——
Q1 '26$0-$120.6M$-0.71——
Q4 '25$0-$106.4M$-0.64——
Q3 '25$0-$111.1M$-0.76——
Q2 '25$0-$109.1M$-0.74——
Q1 '25$0-$87.2M$-0.60——
Q4 '24$0-$75.3M$-0.52——
Get Your Daily Market Recap